Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

Summary

This study is conducted to investigate the effect of the oral renin inhibitor SPP635 on blood pressure in patients with mild to moderate hypertension.

Timeline

Start

2006-10

Primary completion

—

Completion

2007-05

Drugs

Indications